drugset / Trial / NCT06984926
A Study to Test How Well Multiple Doses of BI 3810477 Are Tolerated by Healthy Adults
RandomizedParallel-groupSingle-blindTreatment
Summary
The main objectives of this trial are to investigate safety, tolerability, and pharmacokinetics of BI 3810477 in healthy male and female trial participants when given as multiple rising doses.
Timeline
- Start
- 2025-06-06
- Primary completion
- 2026-03-09
- Completion
- 2026-03-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 3810477 | Unknown | — | — |
Indications
No indication recorded.